Targeted immunotherapy for HER2-low breast cancer with 17p loss
- Type
- Retraction
- Notice date
- 4/15/2026 0:00
- Journal
- Science Translational Medicine
- Publisher
- American Association for the Advancement of Science (AAAS)
- Notice DOI
- 10.1126/scitranslmed.aeh3593
- Original paper DOI
- 10.1126/scitranslmed.abc6894
Reasons
- Falsification/Fabrication of Image
- Investigation by Company/Institution
- Misconduct - Official Investigation(s) and/or Finding(s)
- Misconduct by Author
- Objections by Author(s)